Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 2:42 AM
Ignite Modification Date: 2025-12-25 @ 2:42 AM
NCT ID: NCT01651533
Eligibility Criteria: Inclusion Criteria: * a Fugl-Meyer score \> 27, which is indicative of minimal to moderate arm impairment; * stroke experienced \> 6 months prior to study enrollment; * minimal cognitive impairment, a score \> 25 on the Folstein Mini Mental Status Examination (MMSE); * age \> 21 years old and \< 80 years old; * have experienced one clinical stroke as verified by a physician; * discharged from all forms of physical rehabilitation targeting the affected arm. Exclusion Criteria: * \< 21 years old; * excessive pain in the affected hand, arm or shoulder, as measured by a score \> 5 on a 10-point visual analog scale; * excessive spasticity in the affected biceps, triceps, wrist, or fingers, as defined as a score of greater than or equal to 2 on the Modified Ashworth Spasticity Scale; * currently participating in any experimental rehabilitation or drug studies targeting UE; * mirrors movements(i.e., involuntary movements by the unaffected hand during attempts at unilateral movement by the stroke-affected hand during attempts at unilateral movement by the stroke-affected hand); * history of parietal stroke (because some data suggest that ability to estimate manual motor performance through mental imagery is disturbed after parietal lobe damage); * affected arm joint restriction that in the opinion of the investigator would hinder study participation
Healthy Volunteers: False
Sex: ALL
Minimum Age: 21 Years
Maximum Age: 80 Years
Study: NCT01651533
Study Brief:
Protocol Section: NCT01651533